These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 2021295)

  • 21. Cerebrospinal fluid homovanillic acid in male alcoholics: effects of disulfiram.
    Major LF; Ballenger JC; Goodwin FK; Brown GL
    Biol Psychiatry; 1977 Oct; 12(5):635-42. PubMed ID: 588644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lifetime and current mood and anxiety disorders in short-term and long-term abstinent alcoholics.
    Fein G
    Alcohol Clin Exp Res; 2013 Nov; 37(11):1930-8. PubMed ID: 23895247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluoxetine versus placebo in depressed alcoholic cocaine abusers.
    Cornelius JR; Salloum IM; Thase ME; Haskett RF; Daley DC; Jones-Barlock A; Upsher C; Perel JM
    Psychopharmacol Bull; 1998; 34(1):117-21. PubMed ID: 9564208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depression and its treatment in alcoholics: a review.
    O'Sullivan K
    Can J Psychiatry; 1984 Aug; 29(5):379-84. PubMed ID: 6434175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sex-specific association of depressive disorder and transient emotional states with alcohol consumption in male and female alcoholics.
    Karpyak VM; Geske JR; Hall-Flavin DK; Loukianova LL; Schneekloth TD; Skime MK; Seppala M; Dawson G; Frye MA; Choi DS; Biernacka JM
    Drug Alcohol Depend; 2019 Mar; 196():31-39. PubMed ID: 30660937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Buspirone treatment of alcoholism: age of onset, and cerebrospinal fluid 5-hydroxyindolacetic acid and homovanillic acid concentrations, but not medication treatment, predict return to drinking.
    George DT; Rawlings R; Eckardt MJ; Phillips MJ; Shoaf SE; Linnoila M
    Alcohol Clin Exp Res; 1999 Feb; 23(2):272-8. PubMed ID: 10069556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebrospinal fluid GABA and cyclic nucleotides in alcoholics with and without seizures.
    Goldman GD; Volicer L; Gold BI; Roth RH
    Alcohol Clin Exp Res; 1981; 5(3):431-4. PubMed ID: 6269455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An examination of depressed vs. nondepressed alcoholics in inpatient treatment.
    McMahon RC; Davidson RS
    J Clin Psychol; 1986 Jan; 42(1):177-84. PubMed ID: 3950005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebrospinal fluid amine metabolites. Relationships with behavioral measurements in depressed, manic, and healthy control subjects.
    Redmond DE; Katz MM; Maas JW; Swann A; Casper R; Davis JM
    Arch Gen Psychiatry; 1986 Oct; 43(10):938-47. PubMed ID: 2428328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients. A 5-year follow-up study.
    Roy A; De Jong J; Linnoila M
    Arch Gen Psychiatry; 1989 Jul; 46(7):609-12. PubMed ID: 2472124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoamine metabolites in CSF and suicidal behavior.
    Träskman L; Asberg M; Bertilsson L; Sjöstrand L
    Arch Gen Psychiatry; 1981 Jun; 38(6):631-6. PubMed ID: 6166274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A framework for relating alcoholism and depression.
    Sedlacek DA; Miller SI
    J Fam Pract; 1982 Jan; 14(1):41-4. PubMed ID: 7054369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depression and alcoholism: clinical considerations in management.
    Pary R; Lippmann S; Tobias CR
    South Med J; 1988 Dec; 81(12):1529-33. PubMed ID: 3059516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CSF monoamine metabolite and beta endorphin levels in recently detoxified alcoholics and healthy controls: prediction of alcohol cue-induced craving?
    Petrakis IL; Trevisan L; D'Souza C; Gil R; Krasnicki S; Webb E; Heninger G; Cooney N; Krystal JH
    Alcohol Clin Exp Res; 1999 Aug; 23(8):1336-41. PubMed ID: 10470976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alcoholism and suicide.
    Roy A; Linnoila M
    Suicide Life Threat Behav; 1986; 16(2):244-73. PubMed ID: 2428141
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.
    Carpenter LL; Moreno FA; Kling MA; Anderson GM; Regenold WT; Labiner DM; Price LH
    Biol Psychiatry; 2004 Sep; 56(6):418-26. PubMed ID: 15364040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lifetime rates of alcoholism in adults with anxiety, depression, or co-morbid depression/anxiety: a community survey of Ontario.
    Gratzer D; Levitan RD; Sheldon T; Toneatto T; Rector NA; Goering P
    J Affect Disord; 2004 Apr; 79(1-3):209-15. PubMed ID: 15023496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of alcohol detoxification on anxiety and depressive symptoms.
    Liappas J; Paparrigopoulos T; Tzavellas E; Christodoulou G
    Drug Alcohol Depend; 2002 Oct; 68(2):215-20. PubMed ID: 12234651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Attempted suicide characteristics and cerebrospinal fluid amine metabolites in depressed inpatients.
    Mann JJ; Malone KM; Sweeney JA; Brown RP; Linnoila M; Stanley B; Stanley M
    Neuropsychopharmacology; 1996 Dec; 15(6):576-86. PubMed ID: 8946432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysphoria in male alcoholics with a history of hallucinations.
    Hayne CH; Louks JL
    J Nerv Ment Dis; 1991 Jul; 179(7):415-9. PubMed ID: 1869870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.